journal article·2024-04-17

Glycan-Imprinted Nanoparticle as Artificial Neutralizing Antibody for Efficient HIV-1 Recognition and Inhibition

Juntao Zhou, Libian Wang, Xiaoyan Liu, Yanxin Gai, Mingming Dong, Chu Wang, Muhammad Mujahid Ali, Mingliang Ye, Xianghui Yu, Lianghai Hu

Nano Letters· Volume 24· Issue 15
Publisher page

Abstract

The HIV-1 envelope is a heavily glycosylated class 1 trimeric fusion protein responsible for viral entry into CD4 + immune cells. Developing neutralizing antibodies against the specific envelope glycans is an alternative method for antiviral therapies. This work presents the first-ever development and characterization of artificial neutralizing antibodies using molecular imprinting technology to recognize and bind to the envelope protein of HIV-1. The prepared envelope glycan-imprinted nanoparticles (GINPs) can successfully prevent HIV-1 from infecting target cells by shielding the glycans on the envelope protein. In vitro experiments showed that GINPs have strong affinity toward HIV-1 (K d = 36.7 ± 2.2 nM) and possess high anti-interference and specificity. GINPs demonstrate broad inhibition activity against both tier 1 and tier 2 HIV-1 strains with a pM-level IC 50 and exhibit a significant inhibitory effect on long-term viral replication by more than 95%. The strategy provides a promising method for the inhibition and therapy of HIV-1 infection.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: HIV Research and Treatment · Blood groups and transfusion · HIV/AIDS drug development and treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center for Supramolecular Chemical Biology, National Engineering Laboratory of AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, Jilin 130012, China

CAS Key Laboratory of Separation Sciences for Analytical Chemistry, National Chromatographic R&A Center, Dalian Institute of Chemical Physics, Chinese Academy of Sciences Dalian, Liaoning 116023, China

University of Chinese Academy of Sciences, Beijing, 100049, China

Funding

State Key Laboratory of Analytical Chemistry for Life Sciences · National Key Research and Development Program of China · National Natural Science Foundation of China

References (49)

Show source-provided references
1. UNAIDS. Fact Sheet: Global HIV statistics; Joint United Nations Programme on HIV/AIDS: Geneva, Switzerland, 2023. www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf (2023-11-06).
2. 10.1016/j.bbagen.2019.05.01210.1016/j.bbagen.2019.05.012 ↗
3. 10.1016/j.tim.2022.02.00410.1016/j.tim.2022.02.004 ↗
4. 10.1016/j.chom.2020.03.01810.1016/j.chom.2020.03.018 ↗
5. 10.1146/annurev-immunol-032712-09591610.1146/annurev-immunol-032712-095916 ↗
6. 10.1097/COH.000000000000074210.1097/COH.0000000000000742 ↗
7. 10.1038/s41591-021-01509-010.1038/s41591-021-01509-0 ↗
8. 10.2215/CJN.0224021810.2215/CJN.02240218 ↗
9. 10.1016/S0140-6736(21)00314-710.1016/S0140-6736(21)00314-7 ↗
10. 10.1016/S2352-3018(23)00061-910.1016/S2352-3018(23)00061-9 ↗
11. 10.1038/ncomms1495410.1038/ncomms14954 ↗
12. 10.1073/pnas.200026011710.1073/pnas.2000260117 ↗
13. 10.1126/science.aad245010.1126/science.aad2450 ↗
14. 10.1146/annurev-biophys-060414-03415610.1146/annurev-biophys-060414-034156 ↗
15. 10.1073/pnas.100649810710.1073/pnas.1006498107 ↗
16. 10.1038/nature1380810.1038/nature13808 ↗
17. 10.1002/bit.2736110.1002/bit.27361 ↗
18. 10.1016/0968-0004(94)90034-510.1016/0968-0004(94)90034-5 ↗
19. 10.1039/C8CS00768C10.1039/C8CS00768C ↗
20. 10.1126/science.121325610.1126/science.1213256 ↗
21. 10.1097/COH.000000000000080210.1097/COH.0000000000000802 ↗
22. 10.1093/infdis/jiaa37710.1093/infdis/jiaa377 ↗
23. 10.1146/annurev-immunol-080219-02362910.1146/annurev-immunol-080219-023629 ↗
24. 10.1080/22221751.2020.171370710.1080/22221751.2020.1713707 ↗
25. 10.1038/1926710.1038/19267 ↗
26. 10.1039/C6CS00061D10.1039/C6CS00061D ↗
27. 10.1002/adma.20180632810.1002/adma.201806328 ↗
28. 10.1002/ange.20221393810.1002/ange.202213938 ↗
29. 10.1002/anie.20190486010.1002/anie.201904860 ↗
30. 10.1002/advs.20220268910.1002/advs.202202689 ↗
31. 10.1002/anie.20201295610.1002/anie.202012956 ↗
32. 10.1002/anie.20200530910.1002/anie.202005309 ↗
33. 10.1101/cshperspect.a00692410.1101/cshperspect.a006924 ↗
34. 10.1074/jbc.M111.27445610.1074/jbc.M111.274456 ↗
35. 10.1073/pnas.100649810710.1073/pnas.1006498107 ↗
36. 10.1038/nprot.2017.01510.1038/nprot.2017.015 ↗
37. 10.1038/326662a010.1038/326662a0 ↗
38. 10.1038/s41598-017-10714-210.1038/s41598-017-10714-2 ↗
39. 10.1016/S0065-3527(08)60025-110.1016/S0065-3527(08)60025-1 ↗
40. 10.1055/s-0031-128328710.1055/s-0031-1283287 ↗
41. 10.1016/j.ymthe.2019.07.02110.1016/j.ymthe.2019.07.021 ↗
42. 10.1093/glycob/cwh10610.1093/glycob/cwh106 ↗
43. 10.1038/s41594-022-00852-110.1038/s41594-022-00852-1 ↗
44. 10.1042/BA2006001610.1042/BA20060016 ↗
45. 10.1073/pnas.220079411910.1073/pnas.2200794119 ↗
46. 10.1016/j.immuni.2016.10.02710.1016/j.immuni.2016.10.027 ↗
47. 10.1016/j.clim.2023.10980910.1016/j.clim.2023.109809 ↗
48. 10.1016/j.cell.2019.06.03010.1016/j.cell.2019.06.030 ↗
49. 10.1371/journal.ppat.100361810.1371/journal.ppat.1003618 ↗